Your browser doesn't support javascript.
How to Provide the Needed Protection from COVID-19 to Patients with Hematologic Malignancies.
Ribas, Antoni; Dhodapkar, Madhav V; Campbell, Katie M; Davies, Faith E; Gore, Steven D; Levy, Ronald; Greenberger, Lee M.
  • Ribas A; Department of Medicine and Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California. aribas@mednet.ucla.edu.
  • Dhodapkar MV; Department of Hematology and Medical Oncology at the Winship Cancer Institute of Emory University, Atlanta, Georgia.
  • Campbell KM; Department of Medicine and Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California.
  • Davies FE; Department of Medicine and Perlmutter Cancer Center, New York University, New York, New York.
  • Gore SD; AACR Hematologic Malignancies Task Force, Philadelphia, Pennsylvania.
  • Levy R; AACR Hematologic Malignancies Task Force, Philadelphia, Pennsylvania.
  • Greenberger LM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Blood Cancer Discov ; 2(6): 562-567, 2021 11.
Article in English | MEDLINE | ID: covidwho-1518191
ABSTRACT
Patients with hematologic malignancies are particularly vulnerable to COVID-19 infections, and upon a pooled data analysis of 24 publications, there is evidence that they have suboptimal antibody responses to COVID-19 vaccination and boosters. To provide them the needed additional protection from COVID-19, it is imperative to achieve a 100% full immunization rate in health care workers and adult caretakers, and to foster research to test higher doses and repeated rounds of COVID-19 vaccines and the use of passive immune prophylaxis and therapy.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hematologic Neoplasms / COVID-19 Topics: Vaccines Limits: Adult / Humans Language: English Journal: Blood Cancer Discov Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Hematologic Neoplasms / COVID-19 Topics: Vaccines Limits: Adult / Humans Language: English Journal: Blood Cancer Discov Year: 2021 Document Type: Article